Test Directory

Clear All
Test Code
BCABL
Test Name
BCR-ABL1, p210 with Interpretation
CPT Codes
81206, G0452
Included Tests
  • Quantitative BCR-ABL1, Major (p210), Result
  • Quantitative BCR-ABL1, Major (p210), IS Percent
  • Quantitative BCR-ABL1, Major (p210), Molecular Response
Expected Turnaround Time
1 - 3 days
Clinical Utility

The use of this assay aids physicians in determining whether a major molecular response (MMR) has been achieved in Chronic Myeloid Leukemia (CML) patients, indicating progression-free survival. Increases in BCR-ABL/ABL %IS may indicate a loss of response, or resistance to therapy. The test measures BCR-ABL1 to ABL1 percent ratio on the International Scale (IS) in t(9;22) positive CML patients. Identifies major breakpoint, p210, fusion transcripts e13a2 and e14a2.
Specimen and Container Info

Specimen Type: Whole Blood

  

Collection Container: Lavender Top (EDTA)

    

Desired Specimen Volume: 4 mL

Minimum Acceptable Volume: 4 mL
Transport Instructions

Transport to the laboratory refrigerated. 
Stability Requirements

Refrigerated

3 days
Causes for Rejection
  • Any specimen with leakage on the outside of the container will be rejected. Ensure the lid is tightly closed.
  • Any specimen shared with another laboratory test will be rejected.
  • Any specimen collected in an outdated collection tube will be rejected.
Methodology
Quantitative Reverse Transcription Polymerase Chain Reaction
Reference Intervals
BCR-ABL1 p210 transcripts Not Detected
Performing Location
Roble Road Core Laboratory
Alternate Names
  • Quantitative BCR-ABL1, Major (p210)
  • t(9;22) BCR-ABL1 Translocation
  • Philadelphia Chromosome, Major
Testing Schedule
Routine, Monday - Friday no holidays
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.